<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Neuropsychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Neuropsychiatry</journal-id>
<journal-id journal-id-type="publisher-id">MNP</journal-id>
<journal-title-group>
<journal-title>Molecular Neuropsychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">2296-9209</issn>
<issn pub-type="epub">2296-9179</issn>
<publisher>
<publisher-name>S. Karger AG</publisher-name>
<publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28277568</article-id>
<article-id pub-id-type="pmc">5318929</article-id>
<article-id pub-id-type="doi">10.1159/000453266</article-id>
<article-id pub-id-type="publisher-id">mnp-0002-0219</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mulligan</surname>
<given-names>Kimberly A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheyette</surname>
<given-names>Benjamin N.R.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>a</sup>Department of Biological Sciences, California State University, Sacramento, CA, USA</aff>
<aff id="aff2"><sup>b</sup>Department of Psychiatry, Kavli Institute for Fundamental Neuroscience, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA</aff>
<author-notes>
<corresp id="cor1">*Benjamin N.R. Cheyette, Department of Psychiatry, Kavli Institute for Fundamental Neuroscience, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA 94143 (USA), E-Mail <email>bc@ucsf.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>2</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>2</volume>
<issue>4</issue>
<fpage>219</fpage>
<lpage>246</lpage>
<permissions>
<copyright-statement>Copyright © 2017 by S. Karger AG, Basel</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>Mounting evidence indicates that Wnt signaling is relevant to pathophysiology of diverse mental illnesses including schizophrenia, bipolar disorder, and autism spectrum disorder. In the 35 years since Wnt ligands were first described, animal studies have richly explored how downstream Wnt signaling pathways affect an array of neurodevelopmental processes and how their disruption can lead to both neurological and behavioral phenotypes. Recently, human induced pluripotent stem cell (hiPSC) models have begun to contribute to this literature while pushing it in increasingly translational directions. Simultaneously, large-scale human genomic studies are providing evidence that sequence variation in Wnt signal pathway genes contributes to pathogenesis in several psychiatric disorders. This article reviews neurodevelopmental and postneurodevelopmental functions of Wnt signaling, highlighting mechanisms, whereby its disruption might contribute to psychiatric illness, and then reviews the most reliable recent genetic evidence supporting that mutations in Wnt pathway genes contribute to psychiatric illness. We are proponents of the notion that studies in animal and hiPSC models informed by the human genetic data combined with the deep knowledge base and tool kits generated over the last several decades of basic neurodevelopmental research will yield near-term tangible advances in neuropsychiatry.</p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>Animal model</kwd>
<kwd>Autism</kwd>
<kwd>Bipolar disorder</kwd>
<kwd>Genes</kwd>
<kwd>Glycogen synthase kinase 3</kwd>
<kwd>Induced pluripotent stem cells</kwd>
<kwd>Lithium</kwd>
<kwd>Molecular psychiatry</kwd>
<kwd>Neurodevelopment</kwd>
<kwd>Schizophrenia</kwd>
<kwd>Wnt signaling</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="8"></table-count>
<ref-count count="351"></ref-count>
<page-count count="28"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>